Lucas Ward
Stock Analyst at Ascendiant Capital
(0.46)
# 4,209
Out of 5,147 analysts
26
Total ratings
23.08%
Success rate
-37.45%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $9 → $9.2 | $2.79 | +230.22% | 4 | Dec 22, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $1.40 | +292.86% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $12 → $11 | $3.11 | +260.13% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $2.74 | +739.42% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.99 | +111.06% | 6 | Nov 20, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $135,000 → $108,000 | $2.47 | +4,372,369.64% | 2 | Jul 29, 2024 |
HeartSciences
Dec 22, 2025
Maintains: Buy
Price Target: $9 → $9.2
Current: $2.79
Upside: +230.22%
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $1.40
Upside: +292.86%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $3.11
Upside: +260.13%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $2.74
Upside: +739.42%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.99
Upside: +111.06%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $135,000 → $108,000
Current: $2.47
Upside: +4,372,369.64%